 鲜花( 85)  鸡蛋( 2)
|

楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval2 J- p0 L/ Z" [) `
2 U4 D3 e# T7 w- z& J5 LEDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.4 M4 W# t4 K3 @) Y# t) i
! R U4 e$ I* j! u& y9 a+ ]! F
BY THE EDMONTON JOURNAL FEBRUARY 16, 2007# t8 |4 _9 R& {: Q
2 n/ e$ I, H) P+ y. p1 h* z7 N , s4 {9 T( a$ [% I- g {
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
: Q0 A3 {: X; [) _2 p. S) V: L, _; p1 u' J( @5 p" y e( q
The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."
8 e1 e. _5 d; o4 e( D, V
2 n) Y6 ^0 O' L3 t* w5 NThe APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.
: S. a$ L# y! Y5 e# j- w9 n$ D
5 m$ c/ G+ w7 `) R6 }- dIt should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.4 w- _2 o) d( R+ T; I4 ~4 a
0 ` t. S# p8 I" FIt certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.2 {! i' l. \/ L
: I2 K* x4 C4 m/ N; [0 y& u
"As a scientist, it's one of the highlights of my CAREER," Shan said.
3 w/ u8 Q4 B- |' U1 t2 W+ l
, p; B: L2 h( ?; u# J"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."3 C$ c* a' U& P- Q
; R, N+ r& Z' V3 c# B% S3 ZIt's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.: G5 c& H: h& x3 K( q
( \1 U" f5 d* S \
Ginseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
& ^, W6 e1 }1 A8 b a
7 @3 ^; ~0 b3 n' [( t" KThe approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.* _% [% L' w; I/ B2 i0 y
, H; i; B. F9 l/ ^" D
6 u. A/ y# z' v) L3 y$ R) k
http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|